Taiho Oncology, Inc.
Masashi Shimura has a strong background in biostatistics and has held various roles in the field. Masashi began their career in 2013 as an Assistant Manager of Biostatistics at Taiho Pharmaceutical Co., Ltd. In 2019, they joined Taiho Oncology, Inc. as a Manager of Biostatistics and later became a Senior Manager in January 2022. Their work experience spans both companies, with no end dates provided for any of their roles.
Masashi Shimura obtained a PhD in Biostatistics from the University of Tsukuba.
This person is not in any teams
This person is not in any offices
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com